China NMPA Drug Inspection - Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd. - Weikangling Capsules
China NMPA drug inspection for Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd. published October 31, 2019. Drug: Weikangling Capsules. The Hubei Province Drug Quality Bulletin, issued by the Hubei Provincial Food and Drug Administration, detailed the outc
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd. published October 31, 2019. Drug: Weikangling Capsules. The Hubei Province Drug Quality Bulletin, issued by the Hubei Provincial Food and Drug Administration, detailed the outc
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox